✦ LIBER ✦

Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial

✍ Scribed by R. Ihl; M. Tribanek; N. Bachinskaya

Book ID: 119303841
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 372 KB
Volume: 299
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2010.08.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Ginkgo biloba Extract EGb 761

Effects of Ginkgo biloba Extract EGb 761®on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial

✍ Andrey Scripnikov; Alexander Khomenko; Oleksandr Napryeyenko; for the GINDEM-NP 📂 Article 📅 2007 🏛 Springer Vienna 🌐 German ⚖ 144 KB

Efficacy and safety of a once-daily form

Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

✍ Ralf Ihl; Natalia Bachinskaya; Amos D. Korczyn; Veronika Vakhapova; Michael Trib 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract ## Objective To test the efficacy and safety of a once‐daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. ## Methods Multi‐centre trial of 410 outpatients with mild to moderate dementia (Alzheimer's disease, vascular dementia or mi

Ginkgo biloba extract EGb 761® in dement

Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg

✍ Horst Herrschaft; Anatol Nacu; Sergey Likhachev; Ilya Sholomov; Robert Hoerr; Sa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 384 KB